Otsuka (OTCMKTS:OTSKY) Issues Quarterly Earnings Results

Otsuka (OTCMKTS:OTSKY) released its quarterly earnings results on Friday. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.05, Zacks reports. The business had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.42 billion. Otsuka had a net margin of 15.50% and a return on equity of 12.86%.

Otsuka Stock Performance

OTCMKTS:OTSKY traded down $0.95 during midday trading on Friday, reaching $37.93. The stock had a trading volume of 27,515 shares, compared to its average volume of 35,055. Otsuka has a 1-year low of $26.11 and a 1-year high of $40.92. The firm’s fifty day simple moving average is $37.35 and its 200-day simple moving average is $34.83. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.21 and a quick ratio of 1.65. The stock has a market capitalization of $40.74 billion, a P/E ratio of 15.23, a PEG ratio of 2.79 and a beta of 0.09.

Analysts Set New Price Targets

Separately, Zacks Research raised Otsuka from a “hold” rating to a “strong-buy” rating in a report on Friday, October 9th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy”.

About Otsuka

Otsuka Holdings Co, Ltd. is a Japan-based healthcare company that manages a group of businesses focused primarily on pharmaceuticals, nutraceuticals, and consumer health products. Through its subsidiaries, the company researches, develops, manufactures, and markets prescription medicines, over-the-counter products, functional foods, and beverages.

Its pharmaceutical operations address areas including psychiatry, oncology, cardiovascular and renal diseases, and several other specialty conditions.